Hemorrhage irrigation reduces need for repeat operations in the most common neurosurgery emergency procedure
According to a study published in The Lancet, irrigation during a craniostomy for a chronic subdural hemorrhage is worthwhile. The randomized comparative trial of five centers is historic in the field of neurosurgery in Finland.

The Finnish study of intraoperative irrigation versus drain alone after evacuation of chronic subdural haematoma (FINISH) investigated whether it is worthwhile to irrigate a chronic subdural hematoma during surgery
Half the patients had their hemorrhage irrigated and half did not. Otherwise, the procedure was carried out in the same way. The main result was that there was significantly less need for repeat procedures in patients who had their hemorrhage irrigated during surgery. Patients’ functional capacity and mortality did not differ between the groups.
The research project involved all Finnish neurosurgery units from the university hospitals of Helsinki, Kuopio, Tampere, Turku, and Oulu. A total of 589 patients with symptomatic chronic subdural hematoma were included in the study.
“Based on the results, we recommend that surgery be performed with irrigation as has been the current treatment protocol in Finland. The role of irrigation in surgery has not been previously studied in a randomized setting and the methods of intervention vary worldwide”, says Co-principal Investigator and Associate Professor Rahul Raj from HUS Neurocenter.
Chronic subdural hematoma requires neurosurgical treatment in the emergency department
Chronic subdural hematoma is the most common condition requiring neurosurgical treatment in the emergency department. Its symptoms may include difficulty walking, loss of strength, speech impediment, memory problems, headaches or epileptic seizures. Without treatment, a hematoma can be fatal. In a trephine craniostomy, a small hole is drilled in the skull and the clot is removed either by irrigating and then inserting a drain or by simply inserting a drain.
Co-principal investigator, Pihla Tommiska, MD, adds that trepanation is one of the most common neurosurgical procedures and the number of operations has increased dramatically in Finland in recent decades.
The study is historic in the field of neurosurgery, as a national randomized comparative study of five centers has never been conducted in Finland before.
The study was designed and implemented in collaboration with the Finnish Centre for Evidence-Based Orthopaedics (FICEBO) research group at the University of Helsinki and HUS. The group is internationally renowned for its randomized comparative studies
”When Rahul Raj, Pihla Tommiska and Kimmo Lönnrot presented their research idea in 2019, it was immediately clear to us that FICEBO would be putting its expertise and resources at the disposal of a great idea and ambitious young researchers. Our hope is that FINISH research can encourage young researchers to do more sustained research work," say Professor Teppo Järvinen and Research Director, Associate Professor Simo Taimela.
The study was published in The Lancet journal on June 6, 2024
Reference:
Raj R*, Tommiska P*, Koivisto T, Leinonen V, Danner N, Posti JP, Laukka D, Luoto TM, Rauhala M, Tetri S, Korhonen TK, Satopää J, Kivisaari R, Luostarinen T, Schwartz C, Czuba T, Taimela S, Lönnrot K*, Järvinen TLN* on behalf of the Finnish study of intraoperative irrigation versus drain alone after evacuation of CSDH (FINISH) study group. Burr-hole drainage with or without irrigation for chronic subdural haematoma (FINISH): a Finnish, nationwide, parallel-group, multicentre, randomised, controlled, non-inferiority trial. The Lancet 2024; 6 June
Link to the publication: https://doi.org/10.1016/S0140-6736(24)00686-X
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
Keywords
Contacts
Rahul Raj, Associate Professor, Specialist in Neurosurgery
Email: rahul.raj@hus.fi
Pihla Tommiska, MD, Specializing Physician
Email: pihla.tommiska@helsinki.fi
About HUS
HUS Helsinki University Hospital is the biggest provider of specialized healthcare in Finland. Our high expertise is internationally recognized and accredited. As a university hospital, we are on the cutting edge of developing and evaluating our treatment methods and activities.
HUS treats almost 700,000 patients every year. Our more than 27,000 professionals work to provide the best possible care for our patients. We are responsible for organizing specialized health care in the Uusimaa region. The treatment of many rare and difficult diseases in Finland has been centralized to HUS as well.
HUS – Leading healthcare
The HUS media service is available for the media Mon–Thu 10:00 a.m.–4:00 p.m. and Fri 10:00 a.m.–3:00 p.m., tel. 050 427 2875, or via e-mail: viestinta@hus.fi.
hus.fi/en
Alternative languages
Subscribe to releases from HUS
Subscribe to all the latest releases from HUS by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from HUS
Vanlig axeloperation ger ingen nytta för patienten12.12.2025 10:28:37 EET | Pressmeddelande
Den finländska studien FIMPACT (Finnish Subacromial Impingement Arthroscopy Controlled Trial) har i en tioårsuppföljning visat att operationen inte ger någon fördel jämfört med andra behandlingsformer. Den axeldekompressionsoperation som länge använts vid behandling av axelsmärta minskar enligt studien inte smärtan och förbättrar inte heller funktionsförmågan eller livskvaliteten jämfört med placebokirurgi eller intensifierad fysioterapi.
Yleinen olkapään leikkaus ei tuo hyötyä potilaalle12.12.2025 10:28:37 EET | Tiedote
Suomalainen FIMPACT-tutkimus (Finnish Subacromial Impingement Arthroscopy Controlled Trial) on osoittanut kymmenen vuoden seurannassa, ettei leikkauksesta ole hyötyä verrattuna muihin hoitomuotoihin. Pitkään olkakivun hoidossa käytetty avarrusleikkaus ei tutkimusten mukaan paranna kipua, toimintakykyä tai elämänlaatua verrattuna lumeleikkaukseen tai tehostettuun fysioterapiaan.
Common shoulder surgery does not offer benefit to the patient12.12.2025 10:28:37 EET | Press release
The Finnish FIMPACT trial (Finnish Subacromial Impingement Arthroscopy Controlled Trial) has in a follow-up of ten years shown that surgery does not offer any benefit compared to other forms of treatment. According to studies, decompression surgery (arthroscopic subacromial decompression, ASD), which has long been used in the treatment of shoulder pain, does not reduce the pain or improve functional capacity or the quality of life when compared to placebo surgery or intensified physiotherapy.
HUS-sammanslutningens styrelse sammanträder den 15 december11.12.2025 15:14:06 EET | Pressmeddelande
HUS-sammanslutningens styrelse behandlar på sitt möte den 15 december verksamheten och ekonomin i januari–oktober 2025 samt den sista årsprognosen för 2025. Sammanslutningens styrelse ska också behandla HUS långsiktig plan för fastigheter och verksamhetslokaler samt utvecklingen av Kirurgiska sjukhusets fastighet. Föredragningslistan för mötet finns här. Sammanslutningens styrelse leder HUS verksamhet, förvaltning och ekonomi. Sammanslutningens styrelse har 17 ledamöter och av dem är två företrädare för Helsingfors universitet. Sammanslutningens styrelse sammanträder cirka en gång per månad. HUS medietjänst betjänar medier måndag–torsdag kl. 10–16, fredag kl. 10–15 på numret 050 427 2875 eller per e-post på viestinta@hus.fi. Se avvikande öppettider.
HUSin yhtymähallitus kokoontuu 15.12.11.12.2025 15:14:06 EET | Tiedote
HUSin yhtymähallitus käsittelee 15.12. kokouksessaan tammi−lokakuun 2025 toimintaa ja taloutta sekä vuoden 2025 viimeistä vuosiennustetta. Yhtymähallituksen käsiteltäväksi tulee myös HUSin kiinteistöjen ja toimitilojen pitkän aikavälin suunnitelma sekä Kirurgisen sairaalan kiinteistön kehittäminen. Kokouksen esityslistan voi lukea täältä. Yhtymähallitus johtaa HUSin toimintaa, hallintoa ja taloutta. Yhtymähallituksessa on 17 jäsentä, joista kaksi on Helsingin yliopiston edustajia. Yhtymähallitus kokoontuu noin kerran kuukaudessa. HUSin mediapalvelu palvelee mediaa ma–to klo 10–16, pe klo 10–15 numerossa 050 427 2875 tai sähköpostitse viestinta@hus.fi. Katso poikkeusaukioloajat
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom